Advancing Animal Innovations Through the Lens of "One Health"

12:00 PM - 12:45 PM (EDT), Monday, September 21, 2020 ・ Interactive Online Session
The COVID-19 crisis highlights the intersection of human, animal, and environmental health and a need for multifaceted strategies to confront zoonotic disease outbreaks, like the coronavirus. One key feature of a modern One Health approach is establishing risk-proportionate regulations in the U.S. and globally for animal biotechnologies that can play a key role in reducing the impact of zoonotic diseases, reducing antibiotic use in farm animals, and improving human health. The U.S. lags other countries in advancing beneficial animal biotechnology innovations to the marketplace in a timely manner. This panel will explore the value of animal biotech innovation through the lens of One Health and offer concrete policy concepts that our government can implement immediately to drive investment and innovation.
Moderator
photo
Sr Director, Science and Reg Affairs
Biotechnology Innovation Organization
Speakers
photo
CEO
National Association of State Departments of Agriculture
photo
Sr Director, Science and Reg Affairs
Biotechnology Innovation Organization
photo
VP, Agriculture & Industrial Biosolutions Europe
Novozymes
photo
Chief Scientific Officer
Genus plc